SWHR Supports FDA Recommendations to Include Younger Women in Breast Cancer Research Posted on December 8, 2020 by Liz Hay - Resource
SWHR Comments to FDA on MDUFA Reauthorization for Fiscal Years 2023-2027 Posted on November 23, 2020 by Liz Hay - Resource
SWHR Urges FDA OWH to Prioritize Inclusion of Pregnant Women in Clinical Trials Posted on September 9, 2020 by Liz Hay - Resource
SWHR Recommendations to FDA OWH on Strategic Priorities Posted on September 8, 2020 by Liz Hay - Resource
SWHR Recommendations to FDA for PDUFA Reauthorization for FY 2023-27 Posted on August 21, 2020 by Liz Hay - Resource
SWHR Urges Inclusion of At-Risk Women in COVID-19 Research Posted on June 19, 2020 by Liz Hay - Resource
SWHR Urges Inclusion of Pregnant and Lactating Women in COVID-19 Research Posted on March 18, 2020 by Liz Hay - Resource
RESCHEDULED: Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials Posted on February 27, 2020 by Emily Ortman - Event
Women Make Up 72% of Study Participants for FDA-Approved New Drugs in 2019 Posted on February 21, 2020 by Emily Ortman - Blog Post
